Showing 672 news articles about New & experimental HIV treatments

Filters Content type: Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Positive outcomes from Argos AGS-004 Phase 2a trial in patients with HIV

Editor's pick
The Medical News
3 March 2011
New & experimental HIV treatments

Virostatics' VS411 Phase 2a trial results against HIV presented at 18th CROI

Editor's pick
The Medical News
2 March 2011
New & experimental HIV treatments

Tobira reports on PK, safety, of new CCR5 inhibitor cenicriviroc

Editor's pick
Bioportfolio
2 March 2011
New & experimental HIV treatments

Recombinant Interleukin-7 (CYT107) Expands CD4 T-Cells In Gut Mucosa Of Chronically HIV Infected Immunological Non-Responder Patients

Editor's pick
HIV / AIDS News From Medical News Today
2 March 2011
New & experimental HIV treatments

Drug Used Against Alcohol, Cocaine Abuse May Hold Clues in AIDS Cure Quest

Editor's pick
Bloomberg
23 February 2011
New & experimental HIV treatments

Chimerix Pockets $45M to Further Antiviral Development

Editor's pick
Genetic Engineering News
14 February 2011
New & experimental HIV treatments

'Berlin patient' talks about his stem cell transplant

Editor's pick
Bloombery Businessweek (video)
11 February 2011
New & experimental HIV treatments

Gilead refiles for approval of HIV drug

Editor's pick
San Francisco Business Times
11 February 2011
New & experimental HIV treatments

Sangamo's Bet Against AIDS: Gene Therapy

Editor's pick
Bloomberg Business Week
10 February 2011
Pharmaceutical industry

Idenix drops after FDA loosens one hold but slaps on another

Editor's pick
Fierce Biotech
10 February 2011
New & experimental HIV treatments

FDA Puts a Hold on Development of ViiV HIV Drug

Editor's pick
AIDSMeds
10 February 2011
New & experimental HIV treatments

New Cure-Related Research: Antabuse to Flush HIV Reservoir

Editor's pick
AIDSMeds.com
9 February 2011
New & experimental HIV treatments

Math may help calculate way to find new drugs for HIV and other diseases

Editor's pick
Princeton
7 February 2011
New & experimental HIV treatments

Shionogi-ViiV Healthcare initiates 572-Trii fixed-dose combination therapy study for HIV

Editor's pick
The Medical News
3 February 2011
Pharmaceutical industry

KEI comments on Tibotec voluntary licenses of a new HIV-AIDS product

Editor's pick
Knowledge Ecology International
29 January 2011
Pharmaceutical industry

Access to Medicines: Johnson & Johnson/Tibotec AIDS Drug Licenses Exclude Too Many Patients

Editor's pick
MSF
29 January 2011
New & experimental HIV treatments

J&J Generics Deal May Speed AIDS Drug Access in Africa, India

Editor's pick
Bloomberg Business Week
28 January 2011
New & experimental HIV treatments

Tibotec Signs Multiple Agreements With Generic Manufacturers to Provide Access to New HIV Treatment

Editor's pick
Biomedicine
27 January 2011
Weight gain & lipodystrophy

HIV Lipo Drug Egrifta Now Available; Financial Assistance Programs Open

Editor's pick
AIDSMeds
27 January 2011
New & experimental HIV treatments

Gilead Says FDA Won’t Accept Filing for AIDS Pill

Editor's pick
Bloomberg
26 January 2011
New & experimental HIV treatments

Clinical Trial Results Demonstrate Promise for First Non-suppressive HIV Drug

Editor's pick
Business Wire
20 January 2011
New & experimental HIV treatments

Double whammy for HIV: RNA dynamic duo curbs infection in mice

Editor's pick
Nature News
20 January 2011
New & experimental HIV treatments

Scientists reveal complete structure of HIV's outer shell

Editor's pick
Eurekalert
20 January 2011
New & experimental HIV treatments

The 2011 drug patent ‘cliff’ and the evolution of IP valuation

Editor's pick
EATG
12 January 2011